Findings

What do systematic reviews say?

9 questions · 9 findings · 1 reviews · Kidney and Transplant

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 22.2%GRADE not reported 0 · 0%Very low 3 · 33.3%Low 2 · 22.2%Moderate 2 · 22.2%High 0 · 0%

Any anti‐osteoporotic drugs vs placebo

Vertebral fracture by radiography · postmenopausal women with osteoporosis and CKD stages 3‐4

Any anti‐osteoporotic drugs may leads to lower vertebral fracture by radiography compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic… 2021 · Cochrane Headline outcomes only
RR 0.52 [0.39, 0.69]
5 studies · 9054 participants
Low

Any anti‐osteoporotic drugs vs placebo

Clinical fracture · postmenopausal women with osteoporosis and CKD stages 3‐4

Any anti‐osteoporotic drugs showed no clear difference in clinical fracture compared with placebo (moderate certainty).

1 finding from 1 review

Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic… 2021 · Cochrane Headline outcomes only
RR 0.91 [0.79, 1.05]
4 studies · 5827 participants
Moderate

Any anti‐osteoporotic drugs vs placebo

Mean change in BMD of the femoral neck · postmenopausal women with osteoporosis and CKD stages 3‐4

1 finding from 1 review

Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic… 2021 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 6081 participants
Very low

Any anti‐osteoporotic drugs vs placebo

Mean change in BMD of the lumbar spine · postmenopausal women with osteoporosis and CKD stages 3‐4

1 finding from 1 review

Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic… 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 9054 participants
Very low

Any anti‐osteoporotic drugs vs placebo

Total hip BMD · postmenopausal women with osteoporosis and CKD stages 3‐4

1 finding from 1 review

Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic… 2021 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 3998 participants
Very low

Any anti‐osteoporotic drugs vs placebo

Mean change in BMD of the distal radius · postmenopausal women with osteoporosis and CKD stages 3‐4

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Any anti‐osteoporotic drugs vs placebo

Adverse events · postmenopausal women with osteoporosis and CKD stages 3‐4

Any anti‐osteoporotic drugs showed no clear difference in adverse events compared with placebo (moderate certainty).

1 finding from 1 review

Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic… 2021 · Cochrane Headline outcomes only
RR 0.99 [0.98, 1]
5 studies · 9054 participants
Moderate

Any anti‐osteoporotic drugs vs placebo

Death · postmenopausal women with osteoporosis and CKD stages 3‐4

1 finding from 1 review

Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic… 2021 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 4973 participants
Low

Any anti‐osteoporotic drugs vs placebo

QoL · postmenopausal women with osteoporosis and CKD stages 3‐4

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found